Abstract
Neuroendocrine effects of catecholamine receptor-blocking neuroleptic drugs have been investigated in numerous studies (Ackenheil, 1981; Brambilla et al., 1979a; Burt et al., 1977; Carlsson, 1978, Collu et al., 1977; Ettigi et al., 1976; Meltzer et al., 1978; Pandey et al., 1977; Sachar, 1978); in particular, the increase of serum prolactin (PRL) after acute neuroleptic treatment is well documented (Gruen et al., 1978; Langer et al., 1977; Rubin and Hays, 1980, Wode-Helgodt, et al., 1977). There are, however, only a few studies dealing with the neuroendocrine effects of chronic neuroleptic treatment. As both differ distinctly, inferring long-term effects from short-term effects is inappropriate (Ler-ner et al., 1977). Moreover, there are striking differences in the reactivity of the tuberoinfundibular, nigrostrial, mesolimbic, and mesocortical dopaminergic systems to long-term treatment with neuroleptics (Bowers and Rozitis, 1974; Julou et al., 1977).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ackenheil, M., 1981, Biochemical effects of apomorphine: Contribution to schizophrenia research, in: Apomorphine and Other Dopaminomimetics, Vol. 2, Clinical Research (G. L. Gessa and G. U. Corsini, eds.), pp. 215–225, Raven Press, New York.
Ackenheil, M., Albus, M., Müller, F., Müller, T., Welter, D., Zander, K., and Engel, R., 1979, Catecholamine response to short-time stress in schizophrenic and depressive patients, in: Catecholamines: Basic and Clinical Frontiers, Vol. 2 (E. Usdin, A. Coppen, and J. Barchas, eds.), pp. 1937–1941, Pergamon Press, Elmsford, N.Y.
Andén, N. E., Butcher, S. G., Carrodi, H., Fuxe, K., and Ungerstedt, U., 1970, Receptor activity and turnover of dopamine and noradrenaline after neuroleptics, Eur. J. Pharmacol. 11:303.
Aratö, M., Erdös, A., and Polgŕ, M., 1979, Endocrinological changes in patients with sexual dysfunction under long-term neuroleptic treatment, Pharmakopsychiatr. Neuro-psychopharmakol. 12:426.
Bartholini, G., Keller, H. H., and Pletscher, A., 1973, Effect of neuroleptics on endogenous norepinephrine in rat brain, Neuropharmacology 12:751.
Beaumont, P. J. V., Corker, C. S., Friesen, H. G., Kolakowska, T., Mandelbrote, B. M., Marshall, J., Murray, M. A. F., and Wiles, D. H., 1974, The effects of phenothiazines on endocrine function. II. Effects in men and post-menopausal women, Br. J. Psychiatry 124:420.
Bowers, M. B., Jr., and Rozitis, A., 1974, Regional differences in homovanillic acid concentrations after acute and chronic administration of antipsychotic drugs, J. Pharm. Pharmacol. 26:743.
Brambilla, F., Guerrini, A., Gaustalla, A., Rovere, C., and Riggi, F., 1975, Neuroendocrine effects of haloperidol therapy in chronic schizophrenics, Psychopharmacologia 44:17.
Brambilla, F., Bellodi, L., Negri, F., Smeraldi, E., and Malagoli, G., 1979a, Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy: Growth hormone and prolactin response to stimuli, Psychoneuroendocrinology 4:329.
Brambilla, F., Riggi, F., Guerrini, A., Malagoli, G., and Guastalla, A., 1979b, The effect of prolonged sulpiride therapy on pituitary-gonadal function in male psychotic patients, Clin. Ther. 2:91.
Bürki, H. R., Ruch, W., Asper, H., Baggiolini, M., and Stille, G., 1974, Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat, Eur. J. Pharmacol. 27:180.
Burt, D. R., Creese, I., and Snyder, S. H., 1977, Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain, Science 196:326.
Carlsson, A., 1978, Antipsychotic drugs, neurotransmitters, and schizophrenia, Am. J. Psychiatry 135:164.
Christensen, A. V., and Moller-Nielsen, I., 1980. On the supersensitivity of DA-receptors after single and repeated administration of neuroleptics, in: Tardive Dyskinesia (W. E. Fann, R. C. Smith, J. M. Davis, and E. F. Domino, eds.), pp. 35–50, MTP Press, New York.
Collu, R., Jequier, J. C., Leboeuf, J., and Ducharme, J. R., 1977, Endocrine effects of pimozide, a specific dopaminergic blocker, J. Clin. Endocrinol. Metab. 44:981.
Czernik, A., and Kleesiek, K., 1979, Effects of depot neuroleptics on pituitary hormones, Nervenarzt 50:527.
DeRivera, J. L., Lal, S., Ettigi, P., Hontela, S., Muller, H. F., and Friesen, H. G., 1976, Effects of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups, Clin. Endocrinol. 5:273.
de Wied, D., and de Jong, W., 1974, Drug effects and hypothalamic-anterior pituitary function, Annu. Rev. Pharmacol. 14:389.
Ettigi, P., Nair, N. P. V., Lal, S., Cervantes, P., and Guyda, H., 1976, Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy, J. Neurol. Neurosurg. Psychiatry 39:870.
Gerlach, J., 1979, Tardive dyskinesia, Dan. Med. Bull. 26:209.
Gruen, H. P., Sachar, E. J., Langer, G., Altman, N., Leifer, M., Frantz, A., and Halpern, F. S., 1978, Prolactin responses to neuroleptics in normals and schizophrenic subjects, Arch. Gen. Psychiatry 35:108.
Johnstone, E. C., Crow, T. J., and Mashiter, K., 1977, Anterior pituitary hormone secretion in chronic schizophrenia—An approach to neurohumoral mechanisms, Psychol. Med. 7:223.
Julou, L., Scatton, B., and Glowinski, J., 1977, Acute and chronic treatment with neuroleptics: Similarities and differences in their action in nigrostriatal, mesolimbic and mesocortical dopaminergic neurons, in: Advances in Biochemical Psychopharmacology Vol. 16 (E. Costa and G. L. Gessa, eds.), pp. 617–624, Raven Press, New York.
Keller, H. H., Bartholini, G., and Pletscher, A., 1973, Increase of 3-methoxy-4-hydroxypheny-lethylene glycol in rat brain by neuroleptic drugs, Eur. J. Pharmacol. 23:183.
Kirkegaard, C., Bjorum, N., Cohn, D., Faber, J., Lauridsen, U. B., and Nekup, J., 1977, Studies on the influence of biogenic amines and psychoactive drugs on the prognostic value of the TRH stimulation test in endogenous depression, Psychoneuroendocrinology 2:131.
Klawans, H. L., Goetz, C. G., and Perlik, S., 1980, Tardive dyskinesia: Review and update, Am. J. Psychiatry 137:900.
Kolakowska, T., Wiles, D. H., Gelder, M. G. and McNeilly, A. S., 1976, Clinical significance of plasma chlorpromazine levels, Psychopharmacology 49:101.
Lake, C. R., Ziegler, M. G., and Kopin, I. J., 1976, Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man, Life Sci. 18:1315.
Lal, S., De la Vega, C. E., Sourkes, T. L., and Friesen, H. G., 1973, Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum, J. Clin. Endocrinol. Metab. 37:719.
Lal, S., Tolis, G., Martin, J. B., Brown, G. M., and Guyda, H., 1975, Effect of Clonidine on growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone, and thyroid-stimulating hormone in the serum of normal men, J. Clin. Endocrinol. Metab. 41:827.
Lamberg, B. A., Linnoila, M., Fogelholm, R., Olkinuora, M., Kotilainen, P., and Saarinen, P., 1977, The effect of psychotropic drugs on the TSH-response to thyroliberin (TRH), Neuroendocrinology 24:90.
Langer, G., Sachar, E. J., Halpern, F. S., Gruen, P. H., and Solomon, M., 1977, The prolactin response to neuroleptic drugs. A test of dopaminergic blockade: Neuroendocrine studies in normal men, J. Clin. Endocrinol. Metab. 45:996.
Laughren, T. P., Brown, W. A., and Williams, B. W., 1979, Serum prolactin and clinical state during neuroleptic treatment and withdrawal, Am. J. Psychiatry 136:108.
Lerner, P., Nosé, P., Gordon, E. K., and Lovenberg, W., 1977, Haloperidol: Effect of long-term treatment on rat striatal dopamine synthesis and turnover, Science 197:181.
Martin-Du-Pan, R., and Baumann, D., 1979, Neuroendocrine effects of chronic neuroleptic therapy in male psychiatric patients, Psychoneuroendocrinology 3:245.
Matussek, N., Ackenheil, M., Hippius, H., Müller, F., Schroöder, T., Shultes, H., and Wasilewski, B., 1980, Effect of Clonidine on growth hormone release in psychiatric patients and controls, Psychiatry Res. 2:25.
Meltzer, H. Y., and Fang, V. S., 1976, The effect of neuroleptics on serum prolactin in schizophrenic patients, Arch. Gen. Psychiatry 33:279.
Meltzer, H. Y., Goode, D. J., and Fang, V. S., 1978, The effect of psychotropic drugs on endocrine function. I. Neuroleptics, precursors and agonists, in: Psychopharmacology: A Generation of Progress (M. A. Lipton, A. DiMascio, and K. F. Killam, eds.), pp. 509–529, Raven Press, New York.
Müller, F., Bartl, S., Fischer, B., Wörner, J., and Ackenheil, M., 1980, Hormonal studies after long-term treatment with neuroleptics, Abstracts of the 12th CINP Congress, Göteborg, Sweden, p. 255.
Muller, P., and Seeman, P., 1978, Dopaminergic supersensitivity after neuroleptics: Time course and specificity, Psychopharmacology 60:1.
Murray, M. A., Bancroft, J. H., Anderson, D. C., Tennent, T. G., and Carr, P. J., 1975, Endocrine changes in male sexual deviants after treatment with anti-androgens, oestrogens or tranquilizers, J. Endocrinol. 67:179.
Naber, D., Fischer, B., and Ackenheil, M., 1979, Effect of long-term neuroleptic treatment on dopamine tuberoinfundibular system: Development of tolerance? Commun. Psychopharmacol. 3:59.
Naber, D., Ackenheil, M., Laakmann, G., Fischer, B., and von Werder, K., 1980a, Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics, Pharmakopsychiatr. Neuro-Psychopharmakol. 13:325.
Naber, D., Finkbeiner, C., Fischer, B., Zander, K. J., and Ackenheil, M., 1980b, Effect of long-term neuroleptic treatment on prolactin and norepinephrine levels in serum of chronic schizophrenics: Relations to psychopathology and extrapyramidal symptoms, Neuropsychobiology 6:181.
Naber, D., Steinböck, H., and Greil, W., 1980c, Effects of short- and long-term neuroleptic treatment on thyroid function, Prog. Neuropsychopharmacol. 4:199.
Pandey, G. N., Garver, D. L., Tamminga, C., Ericksen, S., Ali, S. L, and Davis, J. M., 1977, Postsynaptic supersensitivity in schizophrenia, Am. J. Psychiatry 134:518.
Rotrosen, J., Angrist, B., Gershon, S., Paquin, J., Branchey, L., Oleshansky, M., Halpern, F., and Sachar, E. J., 1979, Neuroendocrine effects of apomorphine: Characterization of response patterns and application to schizophrenia research, Br. J. Psychiatry 135:444.
Rubin, R. T., and Hays, S. E., 1980, The prolactin secretory response to neuroleptic drugs: Mechanisms, applications and limitations, Psychoneuroendocrinology 5:121.
Rubin, R. T., Poland, R. E., O’Connor, D., Gouin, P. R., and Tower, B. B., 1976, Selective neuroendocrine effects of low-dose haloperidol in normal adult men, Psychopharmacologia 47:135.
Sachar, E. J., 1978, Neuroendocrine response to psychotropic drugs, in: Psychopharmacology: A Generation of Progress (M. A. Lipton, A. DiMascio, and K. F. Killam, eds.), pp. 499–507, Raven Press, New York.
Sarafoff, M., Davis, L., and Rüther, E., 1979, Clozapine induced increase of human plasma norepinephrine, J. Neural Transm. 46:175.
Sekso, M., Solter, M., Banovac, K., Vizner, B., and Petek, M., 1977, The effect of dopaminergic drugs on pituitary hormone release in normal subjects, Acta Med. Iugosl. 31:321.
Shader, R. I., and DiMascio, A., 1970, Psychotropic Drug Side Effects: Clinical and Theoretical Perspectives, Williams & Wilkins, Baltimore.
Wiles, D. H., Kolakowska, T., McNeilly, A. S., Mandelbrote, B. M., and Gelder, M. G., 1976, Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment, Psychol. Med. 6:407.
Wilson, R. G., Hamilton, J. R., Boyd, W. D., Forrest, A. P. M., Cole, E.N., Boyns, A. R., and Griffiths, K., 1975, The effect of long term phenothiazine therapy on plasma prolactin, Br. J. Psychiatry 127:71.
Wode-Helgodt, B., Eneroth, P., Fryö, B., Gullberg, B., and Sedvall, G., 1977, Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients, Acta Psychiatr. Scand. 56:280.
Zander, K. J., Fischer, B., Zimmer, R., and Ackenheil, M., 1981, Long-term neuroleptic treatment of chronic schizophrenic patients: Clinical and biochemical effects of withdrawal, Psychopharmacology 73:43.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Publishing Corporation
About this chapter
Cite this chapter
Naber, D., Müller, F. (1984). Effects of Long-Term Neuroleptic Treatment on Serum Levels of Prolactin, TSH, LH, and Norepinephrine and on α-Adrenergic and Dopaminergic Receptor Sensitivity. In: Shah, N.S., Donald, A.G. (eds) Psychoneuroendocrine Dysfunction. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4529-9_34
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4529-9_34
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4531-2
Online ISBN: 978-1-4684-4529-9
eBook Packages: Springer Book Archive